MDAN-21 is a bivalent opioid ligand that contains both µ-opioid receptor agonists and delta-opioid receptor antagonists. MDAN-21 has a strong analgesic effect and does not produce tolerance in mouse studies. MDAN-21 can effectively inhibit the withdrawal of morphine dependent monkeys and alleviate abnormal pain in the study of rhesus monkeys. MDAN-21 can be used for the study of allodynia[1].
Molecular Weight:
1058.22
CAS Number:
[873573-64-9]
Formula:
C58H71N7O12
Target:
Opioid Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
